earnings

No Surprise Here: BioNTech's Q3 Results Driven by Its COVID-19 Vaccine Program
Motley Fool
Tue, 11/10/20 - 07:47 pm
BioNTech
earnings
vaccines
COVID-19
Novavax Didn't Come Close to Analysts' Q3 Estimates -- and It's No Big Deal
Motley Fool
Tue, 11/10/20 - 10:42 am
Novavax
vaccines
earnings
COVID-19
Why Emergent BioSolutions Slipped on Friday
Motley Fool
Fri, 11/6/20 - 08:45 pm
Emergent BioSolutions
earnings
How BioMarin Beat Expectations in Q3
Motley Fool
Fri, 11/6/20 - 09:55 am
Biomarin
hemophilia A
earnings
How Bristol Myers Squibb Beat Wall Street Estimates in Q3
Motley Fool
Fri, 11/6/20 - 12:39 am
Bristol-Myers Squibb
earnings
AZ’s Q3 results disappoint – but COVID19 vaccine trial is still on track
Pharmaforum
Thu, 11/5/20 - 11:11 am
AstraZeneca
earnings
vaccines
COVID-19
Regeneron Posts Better-Than-Expected Third-Quarter Earnings
TheStreet.com
Thu, 11/5/20 - 10:50 am
Regeneron
earnings
COVID-19
Lundbeck tops Q3 expectations following strong sales of mental health drugs
Pharmaforum
Tue, 11/3/20 - 10:47 am
Lundbeck
earnings
How AbbVie Beat Expectations in Q3
Motley Fool
Sun, 11/1/20 - 01:49 pm
AbbVie
earnings
Humira
Novo Nordisk quietly nabs a rare 'breakthrough' status in NASH for its cash cow
Endpoints
Fri, 10/30/20 - 10:25 am
Novo Nordisk
earnings
NASH
semaglutide
breakthrough therapy
FDA
In early blow to Kenji Yasukawa's R&D revamp, Astellas drops out of the TIGIT race without explanation
Endpoints
Fri, 10/30/20 - 10:17 am
Astellas
earnings
anti-TIGIT
R&D
Why Illumina's Q3 Results Were Better Than They Might Seem
Motley Fool
Fri, 10/30/20 - 10:13 am
Illumina
diagnostics
earnings
Vertex Pharmaceuticals (VRTX) Tops Q3 Earnings and Revenue Estimates
Yahoo/Zacks.com
Fri, 10/30/20 - 10:09 am
Vertex Pharmaceuticals
earnings
Sanofi, despite COVID-19, sees early gains from CEO Hudson's strategy revamp
Fierce Pharma
Thu, 10/29/20 - 12:19 pm
Sanofi
earnings
Dupixent
Paul Hudson
Pharma CEOs
Thank Otezla for Amgen's Q3 Revenue and Earnings Beats
Motley Fool
Thu, 10/29/20 - 12:01 pm
Amgen
earnings
Otezla
Gilead Sales Up 18% in Q3, Thanks to Coronavirus Treatment Remdesivir
Motley Fool
Wed, 10/28/20 - 11:15 pm
Gilead Sciences
earnings
Veklury
remdesivir
COVID-19
Merck raises annual profit outlook as Keytruda drives profit beat
CNBC
Wed, 10/28/20 - 10:39 am
Merck
earnings
Keytruda
2 Fumbles and 1 Gift in Biogen's Latest Earnings Report
Motley Fool
Wed, 10/28/20 - 10:38 am
Biogen
earnings
Spinraza
How Pfizer Missed an Opportunity With Its Q3 Results
Motley Fool
Tue, 10/27/20 - 11:26 pm
Pfizer
earnings
Merck looks ahead to a COVID-19 drug and vaccine—and a Gardasil recovery—as pandemic takes a $2.5B toll
Fierce Pharma
Tue, 10/27/20 - 11:17 pm
Merck
earnings
Gardasil
pandemic
COVID-19

Pages